. . . . . . . . . . . . "[The presence of JAK2, CALR, or MPL mutation is supportive but not essential for diagnosis; approximately 90% of patients carry one of these mutations and 10% are 'triple-negative.' None of these mutations are specific to PMF and are also seen in essential thrombocythemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2015-02-27"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2015-08-25T14:43:17+02:00"^^ . . . . . . . . . . . "v3.0.0.0" . "v3.0.0" .